RESEARCH TRIANGLE PARK, N.C., July 21, 2011 /PRNewswire/ - Patheon (TSX: PTI)
announced today the appointment of Gary Shope to the newly created
position of Chief of Staff, reporting to James C. Mullen, Patheon's
Chief Executive Officer. In this role, Gary will become an added
resource on critical internal activities related to the company's
strategy and its implementation, sites and other real estate, human
resources and communications with key internal and external audiences.
"I first met Gary in 1992 when he was with the Research Triangle
Foundation," said Mr. Mullen. "I was impressed with his skills,
insights and leadership. His career has provided him with a wealth of
experience in developing business relationships and coordinating the
activities of many disparate entities for a common purpose and I look
forward to the many contributions he will make in helping us profitably
grow the organization."
Gary served as vice president of economic development for the Research
Triangle Foundation for 16 years, the owner and developer of the
Research Triangle Park. Prior to his position with the Foundation, he
was the Group Manager, Far East Group at the N.C. Department of
Commerce. Most recently, Gary was recruited to launch the Riyadh
Technology Valley in Saudi Arabia, intended to bring together global
corporations, international academic researchers and government leaders
to promote the kingdom's technology potential. Gary also worked with
Orange County (N.C.) in developing more strategic positioning of the
county for new and existing industry clusters and leveraging economic
development partnerships with the university community.
Gary earned a Master of public administration from the University of
North Carolina at Chapel Hill and he also holds an undergraduate degree
from West Virginia Wesleyan College.
Patheon is a leading global provider of contract development and
manufacturing services to the global pharmaceutical industry. It
provides the highest quality products and services to approximately 300
of the world's leading pharmaceutical and biotechnology companies.
Patheon's services range from preclinical development through
commercial manufacturing of a full array of dosage forms including
parenteral, solid, semi‐solid and liquid forms. Its comprehensive
range of fully integrated Pharmaceutical Development Services includes
pre‐formulation, formulation, analytical development, clinical
manufacturing, scale‐up and commercialization. Its integrated
development and manufacturing network of 10 facilities, eight
development centers and one clinical trial packaging facility, across
North America and Europe, ensures that customer products can be
launched on‐time and with confidence anywhere in the world.
SOURCE Patheon Inc.